Ocular Therapeutix, Inc. (OCUL)
9.205
-0.12
(-1.23%)
USD |
NASDAQ |
Apr 29, 11:33
Ocular Therapeutix Research and Development Expense (TTM) : 197.10M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| EyePoint, Inc. | 221.04M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Vertex Pharmaceuticals, Inc. | 3.929B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Rhythm Pharmaceuticals, Inc. | 166.89M |